New Study of Ketamine in Depression Receives FDA Approval, But Not Medical Marijuana

There has always been a need for intensive clinical research into ketamine’s medical potential, but obtaining approval for such research has always been a problem. For this reason, the FDA’s recent approval of a study into the use of ketamine infusions for depressive disorders has caught the attention of many. It comes after a number […]


Original post here: New Study of Ketamine in Depression Receives FDA Approval, But Not Medical Marijuana

Comments

Popular posts from this blog

Say hello to the Black CannaConference & Expo: the B2B event for black cannabis

The Delaware Senate approves legislation legalizing cannabis

Liquor stores start selling cannabis?